Published on 15 Nov 2023 on Simply Wall St. via Yahoo Finance

Roivant Sciences Ltd. (NASDAQ:ROIV) Analysts Just Cut Their EPS Forecasts Substantially

Today is shaping up negative for Roivant Sciences Ltd. (NASDAQ:ROIV) shareholders, with the analysts delivering a substantial negative revision to this year's forecasts. Revenue and earnings per share (EPS) forecasts were both revised downwards, with analysts seeing grey clouds on the horizon.

After the downgrade, the nine analysts covering Roivant Sciences are now predicting revenues of US$122m in 2024. If met, this would reflect a meaningful 18% improvement in sales compared to the last 12 months. Per-share losses are expected to creep up to US$1.43. Yet prior to the latest estimates, the analysts had been forecasting revenues of US$136m and losses of US$1.26 per share in 2024. Ergo, there's been a clear change in sentiment, with the analysts administering a notable cut to this year's revenue estimates, while at the same time increasing their loss per share forecasts.

Check out our latest analysis for Roivant Sciences